Cargando…
Synthetic Peptide CK2.3 Enhances Bone Mineral Density in Senile Mice
BACKGROUND: Osteoporosis is a silent disease caused by low bone mineral density that results in bone fractures in 1 out of 2 women and 1 in 4 men over the age of 50. Although several treatments for osteopenia and osteoporosis are available, they have severe side effects and new treatments are desper...
Autores principales: | Nguyen, John, Weidner, Hilary, Schell, Lora M., Sequeira, Linda, Kabrick, Ryan, Dharmadhikari, Saurabh, Coombs, Harold, Duncan, Randall L., Wang, Liyun, Nohe, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173331/ https://www.ncbi.nlm.nih.gov/pubmed/30294717 http://dx.doi.org/10.4172/2572-4916.1000190 |
Ejemplares similares
-
CK2.3, a Mimetic Peptide of the BMP Type I Receptor, Increases Activity in Osteoblasts over BMP2
por: Weidner, Hilary, et al.
Publicado: (2019) -
A Novel Peptide, CK2.3, Improved Bone Formation in Ovariectomized Sprague Dawley Rats
por: Sequeira, Linda, et al.
Publicado: (2020) -
Mechanism of CK2.3, a Novel Mimetic Peptide of Bone Morphogenetic Protein Receptor Type IA, Mediated Osteogenesis
por: Vrathasha, Vrathasha, et al.
Publicado: (2019) -
Mechanisms of Cellular Internalization of Quantum Dot® Conjugated Bone Formation Mimetic Peptide CK2.3
por: Vrathasha, Vrathasha, et al.
Publicado: (2018) -
Mathematical modeling of the effects of CK2.3 on mineralization in osteoporotic bone
por: Lisberg, A, et al.
Publicado: (2017)